Journal of the Society for Gynecologic Investigation

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

http://mc.manuscriptcentral.com/rsci

SAGETRACK

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leslie, K. K.
Right arrow Articles by Naftolin, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leslie, K. K.
Right arrow Articles by Keefe, D.
Right arrow Articles by Powell, S.
Right arrow Articles by Naftolin, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of the Society for Gynecologic Investigation, Vol. 1, No. 3, 238-244 (1994)
DOI: 10.1177/107155769400100311

Estrogen Receptors Are Identified in the Glioblastoma Cell Line UI38MG

Kimberly K. Leslie

David Keefe

Susan Powell

Frederick Naftolin

OBJECTIVE: The antiestrogen tamoxifen has been found to be effective in decreasing glioblas toma cell proliferation, but the mechanism underlying this effect and whether it is through the estrogen receptor (ER) is controversial. The objective of this study was to determine whether ERs are present in three human glioblastoma cell lines—HS683, U138MG, and JHN J889H—using the most sensitive techniques available.

METHODS: Ligand binding and flow cytometry were employed to identify estrogen and pro gesterone receptors. The reverse transcriptase-polymerase chain reaction was used to identify ER mRNA, and a novel reporter gene transfection assay demonstrated that the ER was capable of activating gene transcription.

RESULTS: U138MG glioblastoma cells contain ERs that are capable of increasing gene tran scription in response to estradiol. No ERs were found in HS683 or JHN J889H cells.

CONCLUSION: Tamoxifen may be acting through the ER in some glioblastoma cells. (J Soc Gynecol Invest 1994;1:238-44)

Key Words: Glioblastoma cells • tamoxifen • antiestrogens • estrogen receptor • estrogen • gene transcription • progesterone receptor • ligand binding • flow cytometry.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?